v3.25.4
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Feb. 13, 2025
Jan. 22, 2025
Dec. 31, 2024
Dec. 30, 2024
Dec. 03, 2024
Oct. 02, 2024
Sep. 27, 2024
May 09, 2024
Mar. 05, 2024
Jan. 10, 2024
Jan. 09, 2024
Dec. 21, 2023
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Feb. 17, 2025
Officer and directors compensation                           $ 14,131,250      
Liabilities     $ 1,688,077                   $ 13,870,407 13,870,407   $ 1,688,077    
Commitment fee                           1,750,000        
Due to affiliate     $ 111,026                     111,026   $ 353,679
Debt interest rate 20.00% 20.00% 20.00% 20.00%   20.00% 20.00%                      
Principal amount $ 31,250 $ 31,250 $ 279,878 $ 40,625   $ 62,500 $ 1,066,391           9,687,500 9,687,500   $ 279,878    
Gross proceeds $ 2,500,000 $ 2,500,000 $ 2,500,000 $ 2,500,000   $ 2,500,000 $ 2,500,000             257,645      
Debt interest stated percentage 5.00% 5.00% 5.00% 5.00%   5.00% 5.00%                 5.00%    
Debt unamortized discount $ 6,250 $ 6,250 $ 46,646 $ 8,125   $ 12,500 $ 213,278           5,943,425 5,943,425   $ 46,646    
Maturity date             Dec. 10, 2025                      
Amortized debt discount                           2,021,209      
September Twenty Seven Two Thousand Twenty Four [Member]                                    
Amortized debt discount                         0 139,052        
October Two Two Thousand Twenty Four [Member]                                    
Amortized debt discount                         0 8,379        
December Thirty Two Thousand Twenty Four [Member]                                    
Amortized debt discount                         2,708 8,095        
December Thirty First Two Thousand Twenty Four [Member]                                    
Amortized debt discount                         19,476 46,646        
January Twenty Two Two Thousand Twenty Five [Member]                                    
Amortized debt discount                         2,609 6,250        
February Thirteen Two Thousand Twenty Five [Member]                                    
Amortized debt discount                         3,113 6,250        
Affiliates [Member]                                    
Due to affiliate                       353,679 353,679      
Related Party [Member]                                    
Notes payable, current     1,266,832                   885,564 885,564   1,266,832    
Loan and Transfer Agreement [Member] | Sponsor and SSVK Associates LLC Member                                    
Debt     250,000                   250,000 250,000   250,000    
Funded loan amount                       $ 250,000            
Funded amount                       $ 250,000            
Liabilities                                   250,000
Loan and Transfer Agreement [Member] | Apogee Pharma [Member]                                    
Debt     50,000                   50,000 50,000   50,000    
Funded loan amount                     $ 50,000              
Funded amount                     $ 50,000              
Liabilities                                   $ 50,000
Shares issued                                   50,000
Loan and Transfer Agreement [Member] | Jinal Sheth [Member]                                    
Debt     149,214                   149,214 149,214   149,214    
Funded loan amount                   $ 149,214                
Funded amount                   $ 149,214                
Liabilities                                   $ 149,214
Second Loan And Transfer Agreementt [Member] | Apogee Pharma Two [Member]                                    
Debt     50,000                   50,000 50,000   50,000    
Funded loan amount         $ 50,000                          
Funded amount         $ 50,000                          
Liabilities                                   50,000
First Subscription Agreement [Member]                                    
Debt                                   $ 1,500,000
Sponsor contribution                 $ 1,000,000                  
Commitment fee                           1,750,000        
Second Subscription Agreements [Member]                                    
Sponsor contribution               $ 500,000                    
Payments for loans               $ 500,000                    
First And Second Subscription Agreement [Member]                                    
Loan balance                         $ 1,500,000 1,500,000        
Modified Promissory Note Fee Agreement [Member]                                    
Loans payable           $ 1,000,000                        
Related Party Loans [Member]                                    
Loan conversion agreement warrant                           $ 1,500,000        
Conversion price of warrant                         $ 1.50 $ 1.50        
Aspire Biopharma Inc [Member]                                    
Officer and directors compensation                               356,032 $ 100,000  
Debt     0                         0 181,061  
Loans payable     0                         0 360,636  
Convertible debt     0                         0 0  
Accrued interest payable     0                         0 0  
Liabilities     1,688,077                         1,688,077 $ 534,035  
Shares issued                                 150,000  
Sponsor contribution                               257,613  
Due to affiliate     $ 111,026                         111,026 $ 626  
Debt interest rate     20.00% 20.00%   20.00% 20.00%                      
Principal amount     $ 279,878 $ 40,625   $ 62,500 $ 1,066,391                 $ 279,878    
Gross proceeds     $ 2,500,000 $ 2,500,000   $ 2,500,000 $ 2,500,000                      
Debt interest stated percentage     5.00% 5.00%   5.00% 5.00%                 5.00%    
Debt unamortized discount     $ 46,646 $ 8,125   $ 12,500 $ 213,278                 $ 46,646